Abstract
Advances in microneurosurgery, neurocritical care, and endovascular techniques have greatly improved outcomes for patients with complex neurosurgical disorders. The neurosurgeons of today have become involved in the application of high-technology solutions and have welcomed contributions from other disciplines. Less invasive approaches resulting in improved patient outcomes have helped to shift the focus of neurosurgery toward minimally invasive procedures. Currently, this trend is reflected in all aspects of the specialty. One of the most influenced areas is neuroendovascular surgery. With improvement and broad application of refined microsurgery, skull base techniques, computerized surgical guidance, and new catheter technology and embolic agents, this field has advanced quickly, with an ever increasing safety and effectiveness profile.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Luessenhop AJ, Spence WT. Artificial embolization of cerebral arteries: report of use in a case of arteriovenous malformation. JAMA 1960;172:1153–1155.
Jafar JJ, Davis AJ, Berenstein A, Choi IS, Kupersmith MJ. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 1993;78:60–69.
de Oliveira E, Tedeschi H, Raso J. Comprehensive management of arteriovenous malformations. Neurol Res 1998;20:673–683.
Batjer HH, Devous MD, Sr., Meyer YJ, Purdy PD, Samson DS. Cerebrovascular hemodynamics in arteriovenous malformation complicated by normal perfusion pressure breakthrough. Neurosurgery 1988;22:503–509.
Spetzler RF, Wilson CB, Weinstein P, Mehdorn M, Townsend J, Telles D. Normal perfusion pressure breakthrough theory. Clin Neurosurg 1978;25:651–672.
Flickinger JC, Pollock BE, Kondziolka D, Lunsford LD. Adose-response analysis of arteriovenous malformation obliteration after radiosurgery. Int J Radiat Oncol Biol Phys 1996;36:873–879.
Gobin YP, Laurent A, Merienne L, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg 1996;85:19–28.
Wikholm G, Lundqvist C, Svendsen P. The Goteberg cohort of embolized cerebral arteriovenous malformations: a 6-year follow-up. Neurosurgery 2001;49:799–806.
Batjer HH, Purdy PD, Giller CA, Samson DS. Evidence of redistribution of cerebral blood flow during treatment for an intracranial arteriovenous malformation. Neurosurgery 1989;25:599–605.
Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg 2003;98:3–7.
Heros RC. Spetzler-Martin grades IV and V arteriovenous malformations. J Neurosurg 2003;98:1–2.
Porstmann W, Wierny L, Warnke H, Gerstberger G, Romaniuk PA. Catheter closure of patent ductus arteriosus. 62 cases treated without thoracotomy. Radiol Clin North Am 1971;9:203–218.
Standard SC, Guterman LR, Chavis TD, Hopkins LN. Delayed recanalization of a cerebral arteriovenous malformation following angiographic obliteration with polyvinyl alcohol embolization. Surg Neurol 1995;44:109–113.
Debrun GM, Aletich V, Ausman JI, Charbel F, Dujovny M. Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 1997;40:112–121.
Jahan R, Murayama Y, Gobin YP, Duckwiler GR, Vinters HV, Vinuela F. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 2001;48:984–997.
Sampei K, Hashimoto N, Kazekawa K, Tsukahara T, Iwata H, Takaichi S. Histological changes in brain tissue and vasculature after intracarotid infusion of organic solvents in rats. Neuroradiology 1996;38:291–294.
Chaloupka JC, Huddle DC, Alderman J, Fink S, Hammond R, Vinters HV. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol 1999;20:401–410.
Akin ED, Perkins E, Ross IB. Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with N-butyl cyanoacrylate use for embolization of vessels in an arteriovenous malformation resection model in swine. J Neurosurg 2003;98:366–370.
Kerber C, Connors J, III, Knox K. The behavior of a new liquid embolic agent, neuracryl M, in blood. AANS/CNS Section on Cerebrovascular Surgery and American Society of Interventional and Therapeutic Neuroradiology Meeting, Nashville, TN, 1999 (oral presentation).
Kerber CW, Wong W, Knox K, et al. Neuracryl M, a new liquid embolic agent: initial clinical results (abstract). J Neurosurg 2000;92:196.
Chopko BW, Kerber C, Wong W, Knox K, Krall R. Initial neuropathologic observations after treatment of a human arteriovenous malformation with a novel liquid embolic agent, neuracryl-M, American Association of Neurological Surgery/Congress of Neurological Surgeons Section on Cerebrovascular Surgery and American Society of Interventional and Therapeutic Neuroradiology Meeting, New Orleans, LA, 2000 (poster presentation).
Horton JA, Kerber CW. Lidocaine injection into external carotid branches: provocative test to preserve cranial nerve function in therapeutic embolization. AJNR Am J Neuroradiol 1986;7:105–108.
Peters KR, Quisling RG, Gilmore R, Mickle P, Kuperus JH. Intraarterial use of sodium methohexital for provocative testing during brain embolotherapy. AJNR Am J Neuroradiol 1993;14:171–174.
Fournier D, TerBrugge KG, Willinsky R, Lasjaunias P, Montanera W. Endovascular treatment of intracerebral arteriovenous malformations: experience in 49 cases. J Neurosurg 1991;75:228–233.
Fox AJ, Pelz DM, Lee DH. Arteriovenous malformations of the brain: recent results of endovascular therapy. Radiology 1990;177:51–57.
Vinuela F, Dion JE, Duckwiler G, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg 1991;75:856–864.
Bullard DE, Bigner SH, Bigner DD. Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model. Cancer Res 1985;45:5240–5245.
Chiras J. Intra-arterial chemotherapy for the central nervous system, in Interventional Neuroradiology, 1st ed. (Connors J, Wojak J, eds.), WB Saunders, Philadelphia, 1999, pp. 368–371.
Theron J, Villemure JG, Worthington C, Tyler JL. Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations. Neuroradiology 1986;28:118–125.
Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984;2: 498–504.
Defer G, Fauchon F, Schaison M, Chiras J, Brunet P. Visual toxicity following intraarterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas. A prospective study with statistical analysis. Neuroradiology 1991;33:432–437.
Shapiro WR, Green SB, Burger PC, et al. A randomized comparison of intraarterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992;76:772–781.
Stewart DJ, Grahovac Z, Russel NA, et al. Phase I study of intracarotid PCNU. J Neurooncol 1987;5:245–250.
Maiese K, Walker RW, Gargan R, Victor JD. Intra-arterial cisplatin-associated optic and otic toxicity. Arch Neurol 1992;49:83–86.
Tfayli A, Hentschel P, Madajewicz S, et al. Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors. J Neurooncol 1999;42: 73–77.
Qureshi AI, Suri MF, Khan J, et al. Superselective intraarterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures. J Neurooncol 2001;51: 151–158.
Hopkins LN, Lanzino G, Guterman LR. Treating complex nervous system vascular disorders through a “needle stick”: origins, evolution, and future of neuroendovascular therapy. Neurosurgery 2001;48:463–475.
Choi IS, Tantivatana J. Neuroendovascular management of intracranial and spinal tumors. Neurosurg Clin N Am 2000;11:167–185.
Standard SC, Hopkins LN. Principles of neuroendovascular intervention, in Endovascular Neurological Intervention (Maciunas RJ, ed.), The American Association of Neurological Surgeons, Park Ridge, IL, 1995, pp. 1–34.
Ahn HS, Kerber CW, Deeb ZL. Extra-to intracranial arterial anastomoses in therapeutic embolization: recognition and role. AJNR Am J Neuroradiol 1980;1:71–75.
Jungreis CA. Skull-base tumors: ethanol embolization of the cavernous carotid artery. Radiology 1991;181:741–743.
Casasco A, Herbreteau D, Houdart E, et al. Devascularization of craniofacial tumors by percutaneous tumor puncture. AJNR Am J Neuroradiol 1994;15:1233–1239.
Casasco A, Houdart E, Biondi A, et al. Major complications of percutaneous embolization of skull-base tumors. AJNR Am J Neuroradiol 1999;20:179–181.
Manelfe C, Lasjaunias P, Ruscalleda J. Preoperative embolization of intracranial meningiomas. AJNR Am J Neuroradiol 1986;7:963–972.
Richter HP, Schachenmayr W. Preoperative embolization of intracranial meningiomas. Neurosurgery 1983;13:261–268.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Hanel, R.A., Bendok, B.R., Howington, J.U., Levy, E.I., Guterman, L.R., Nelson Hopkins, L. (2005). The Role of Embolic Agents in Endovascular Treatment of Intracranial Arteriovenous Malformations and Tumors. In: Proctor, M.R., Black, P.M. (eds) Minimally Invasive Neurosurgery. Humana Press. https://doi.org/10.1385/1-59259-899-4:187
Download citation
DOI: https://doi.org/10.1385/1-59259-899-4:187
Publisher Name: Humana Press
Print ISBN: 978-1-58829-147-9
Online ISBN: 978-1-59259-899-1
eBook Packages: MedicineMedicine (R0)